Determining if Centene Corporation (NYSE: CNC) is a good buy requires analyzing personal investment strategies, risk tolerance, and healthcare sector outlooks. Wall Street analysts maintain a consensus hold rating with average price targets sitting near $70, though some fundamental models suggest the stock remains undervalued relative to its sales multiples. Investors looking at the stock must evaluate upcoming leadership transitions and medical cost ratio trends before making allocation decisions.